
Canadian startup using nanotechnology to develop non-invasive alternative to pap smears
CELLECT Laboratories is working on a non-invasive technology that could replace the need for pap smears, while still helping people access life-saving screening.

CELLECT Laboratories is working on a non-invasive technology that could replace the need for pap smears, while still helping people access life-saving screening.

Joeyband™ donates 110+ NICU skin-to-skin devices to the Canadian Premature Babies Foundation (CPBF), expanding access to skin-to-skin care for families across Canada.

Duchesnay and PeriPharm announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness about access to innovative medications for women’s health in

A new national survey of commissioned by myStoria reveals a reproductive health system marked by persistent knowledge gaps, widespread provider dismissal, and a near-universal failure of school-based sex education.

Explore why women’s health in defence requires intentional system design, from equipment testing to clinical research, and how we can do it.

HorminaCare, a new virtual healthcare platform dedicated exclusively to women’s hormone health, officially launches its mission to close critical gaps in care by offering accessible, science-backed, root-cause treatment for hormonal

Frustrated by dismissed health symptoms? Learn how Ontario-based HorminaCare is helping women manage hormonal imbalances through personalized telehealth plans and expert nurse practitioners.

HorminaCare, a telehealth platform, utilizes the expertise and experience of nurse practitioners and a proprietary framework to help women navigate their personal hormonal challenges with customized solutions.

Flora Fertility raises a $5 million seed round for its reproductive insurance platform, aiming to expand access to reproductive care.

Coral, the category-defining virtual clinic for midlife women, announced an additional $4 million CAD acceleration round, only one year after its launch.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.